ReviewFrontiers in neurology2024

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.

Jannis Wißfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.